Sanarus provides cryoablation technology that is used to freeze tissue for diagnostic and therapeutic breast care procedures. The company was founded in 2008 and is headquartered in Pleasanton, California.
Visica 2 uses cryoablation to treat biopsy proven fibroadenomas and is currently in a Phase 2 clinical trial for the treatment of breast cancer.
In 2008, the Visica 2 Treatment System was named a runner-up in the Medical Device category at the Wall Street Journal's Technology Innovation Awards.
Sanarus Technologies raises a $15,000,000 series E round from Forward Ventures and Alta Partners.
Documentaries, videos and podcasts